We are live on ! Find out more
Adage Capital Partners

Adage Capital Partners Portfolio holdings

AUM $64.8B
1-Year Est. Return 42.7%
This Fund
S&P 500
This Quarter Est. Return
+9.27%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+879.75%
AUM
$49B
AUM Growth
+$3.11B
Cap. Flow
+$228M
Cap. Flow %
0.47%
Top 10 Hldgs %
21.37%
Holding
1,104
New
303
Increased
294
Reduced
324
Closed
153

Sector Composition

Rank Sector Weight
1 Technology 20.67%
2 Healthcare 17.99%
3 Financials 14.03%
4 Consumer Discretionary 11.97%
5 Communication Services 8.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SPRQ.U
1076
DELISTED
Spartan Acquisition Corp. II Units, each consisting of one share of Class A common stock, and one-ha
SPRQ.U
-2,700,000
Closed -$29.2M
ALUS.WS
1077
DELISTED
Alussa Energy Acquisition Corp Warrants
ALUS.WS
-900,000
Closed -$1.11M
WPF
1078
DELISTED
Foley Trasimene Acquisition Corp.
WPF
-12,842
Closed -$144K
FCACU
1079
DELISTED
Falcon Capital Acquisition Corp. Unit
FCACU
-350,000
Closed -$3.74M
NGA.WS
1080
DELISTED
Northern Genesis Acquisition Corp. Redeemable Warrants, each warrant exercisable for shares of commo
NGA.WS
-1,187,500
Closed -$6.7M
NGA
1081
DELISTED
Northern Genesis Acquisition Corp.
NGA
-624,550
Closed -$11.1M
PRSP
1082
DELISTED
Perspecta Inc. Common Stock
PRSP
-57,988
Closed -$1.4M
STPK.WS
1083
DELISTED
Star Peak Energy Transition Corp. Warrants, each whole warrant exercisable for one share of Class A
STPK.WS
-1,033,333
Closed -$6.12M
GNMK
1084
DELISTED
GenMark Diagnostics, Inc
GNMK
-250,000
Closed -$3.65M
FPRX
1085
DELISTED
Five Prime Therapeutics, Inc.
FPRX
-900,000
Closed -$15.3M
PAND
1086
DELISTED
Pandion Therapeutics Inc. Common Stock
PAND
-199,293
Closed -$2.96M
BFT
1087
DELISTED
Foley Trasimene Acquisition Corp. II
BFT
-1,165,051
Closed -$17.6M
QEP
1088
DELISTED
QEP RESOURCES, INC.
QEP
-1,263,264
Closed -$3.02M
EV
1089
DELISTED
Eaton Vance Corp.
EV
-1,400,000
Closed -$95.1M
SBE.WS
1090
DELISTED
Switchback Energy Acquisition Corporation Warrants, exercisable for one share of Class A Common Stoc
SBE.WS
-95,771
Closed -$1.48M
PANA.WS
1091
DELISTED
Panacea Acquisition Corp. Redeemable warrants, each whole warrant exercisable for one share of Class
PANA.WS
-266,666
Closed -$853K
FSDC
1092
DELISTED
FS Development Corp. Class A Common Stock
FSDC
-1,000,000
Closed -$11M
PRVL
1093
DELISTED
Prevail Therapeutics Inc. Common Stock
PRVL
-600,000
Closed -$13.8M
VRT.WS
1094
DELISTED
Vertiv Holdings Co Warrants, each whole warrant exercisable for one share of Class A Common Stock at
VRT.WS
-400,000
Closed -$2.92M
CXO
1095
DELISTED
CONCHO RESOURCES INC.
CXO
-3,005,400
Closed -$175M
PE
1096
DELISTED
PARSLEY ENERGY INC
PE
-6,593,587
Closed -$93.6M
WPX
1097
DELISTED
WPX Energy, Inc.
WPX
-7,671,800
Closed -$62.5M
TIF
1098
DELISTED
Tiffany & Co.
TIF
-114,754
Closed -$15.1M
BMY.RT
1099
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
-13,725,497
Closed -$9.47M
OZON
1100
DELISTED
Ozon Holdings PLC American Depositary Shares, each ADS representing one ordinary share
OZON
-50,000
Closed -$2.07M

Similar funds

Adage Capital Partners's Q1 2021 Portfolio in Review

As of Q1 2021, Adage Capital Partners held 1,104 positions worth $49B, up 6.8% from $45.9B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Adage Capital Partners's Q1 2021 filing shows 303 new, 294 increased, 324 reduced and 153 closed positions. Its largest new stake was GW Pharmaceuticals Plc American Depositary Shares: 1,500,000 shares worth $325M. The largest sale was Royalty Pharma, an estimated $665M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 21% a quarter earlier, followed by Healthcare and Financials.

  • Adage Capital Partners's largest Q1 2021 buy was GW Pharmaceuticals Plc American Depositary Shares: 1,500,000 shares worth $325M.
  • Adage Capital Partners added most to Alexion Pharmaceuticals in Q1 2021, an estimated $205M increase.
  • Adage Capital Partners's biggest Q1 2021 reduction was Royalty Pharma, cutting an estimated $665M.
  • Adage Capital Partners fully exited CONCHO RESOURCES INC. in Q1 2021, selling an estimated $175M.
  • Adage Capital Partners's ten largest holdings make up 21% of its $49B portfolio in Q1 2021.
  • Adage Capital Partners opened 303 new positions and closed 153 in Q1 2021.
  • Adage Capital Partners's portfolio value rose 6.8% quarter-over-quarter to $49B.

Based on Adage Capital Partners's 13F filing for Q1 2021, filed 17 May 2021.